Your browser doesn't support javascript.
loading
Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions.
Alcala, Nicolas; Mangiante, Lise; Le-Stang, Nolwenn; Gustafson, Corinne E; Boyault, Sandrine; Damiola, Francesca; Alcala, Karine; Brevet, Marie; Thivolet-Bejui, Françoise; Blanc-Fournier, Cécile; Le Rochais, Jean-Philippe; Planchard, Gaëtane; Rousseau, Nathalie; Damotte, Diane; Pairon, Jean Claude; Copin, Marie Christine; Scherpereel, Arnaud; Wasielewski, Eric; Wicquart, Laurence; Lacomme, Stéphanie; Vignaud, Jean-Michel; Ancelin, Gaspard; Girard, Cécile; Sagan, Christine; Bonnetaud, Christelle; Hofman, Véronique; Hofman, Paul; Mouroux, Jérôme; Thomas de Montpreville, Vincent; Clermont-Taranchon, Estelle; Mazieres, Julien; Rouquette, Isabelle; Begueret, Hugues; Blay, Jean-Yves; Lantuejoul, Sylvie; Bueno, Raphael; Caux, Christophe; Girard, Nicolas; McKay, James D; Foll, Matthieu; Galateau-Salle, Françoise; Fernandez-Cuesta, Lynnette.
Afiliação
  • Alcala N; Section of Genetics, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
  • Mangiante L; Section of Genetics, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
  • Le-Stang N; Department of Pathology, Centre Léon Bérard (CLB), Lyon, France.
  • Gustafson CE; Division of Thoracic Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Boyault S; Translational Research and Innovation Platform, Cancer Research Centre of Lyon (CRCL), Lyon, France.
  • Damiola F; Department of Pathology, Centre Léon Bérard (CLB), Lyon, France.
  • Alcala K; Section of Genetics, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
  • Brevet M; Pathology Institute, Hospices Civils de Lyon, University Claude Bernard Lyon 1, France.
  • Thivolet-Bejui F; Pathology Institute, Hospices Civils de Lyon, University Claude Bernard Lyon 1, France.
  • Blanc-Fournier C; Caen University Hospital, CHU Caen, Caen, France.
  • Le Rochais JP; Caen University Hospital, CHU Caen, Caen, France.
  • Planchard G; Caen University Hospital, CHU Caen, Caen, France.
  • Rousseau N; Caen University Hospital, CHU Caen, Caen, France.
  • Damotte D; Paris Centre University Hospital, Paris, France.
  • Pairon JC; Centre Hospitalier Intercommunal Créteil, Créteil, Paris, France.
  • Copin MC; Lille University Hospital, Lille, France.
  • Scherpereel A; Lille University Hospital, Lille, France.
  • Wasielewski E; Lille University Hospital, Lille, France.
  • Wicquart L; Lille University Hospital, Lille, France.
  • Lacomme S; Nancy University Hospital, Nancy, France.
  • Vignaud JM; Nancy University Hospital, Nancy, France.
  • Ancelin G; Nantes University Hospital, Nantes, France.
  • Girard C; Nantes University Hospital, Nantes, France.
  • Sagan C; Nantes University Hospital, Nantes, France.
  • Bonnetaud C; Nice University Hospital, Nice, France.
  • Hofman V; Nice University Hospital, Nice, France.
  • Hofman P; Nice University Hospital, Nice, France.
  • Mouroux J; Nice University Hospital, Nice, France.
  • Thomas de Montpreville V; Marie Lannelongue Hospital, Le Plessis Robinson, France.
  • Clermont-Taranchon E; Toulouse University Hospital, Toulouse, France.
  • Mazieres J; Toulouse University Hospital, Toulouse, France.
  • Rouquette I; Toulouse University Hospital, Toulouse, France.
  • Begueret H; Bordeaux University Hospital, Bordeaux, France.
  • Blay JY; Department of Medical Oncology, Centre Léon Bérard (CLB), Lyon, France; European Reference Network (ENR-EURACAN), France.
  • Lantuejoul S; Department of Pathology, Centre Léon Bérard (CLB), Lyon, France; University Grenoble Alpes, Grenoble, France.
  • Bueno R; Division of Thoracic Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Caux C; Department of Immunity, Virus, and Inflammation, Cancer Research Centre of Lyon (CRCL), Lyon, France.
  • Girard N; European Reference Network (ENR-EURACAN), France; University Lyon 1, Lyon, France; INSERM U932, Paris, France; Institut Curie, Paris, France.
  • McKay JD; Section of Genetics, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
  • Foll M; Section of Genetics, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
  • Galateau-Salle F; Department of Pathology, Centre Léon Bérard (CLB), Lyon, France.
  • Fernandez-Cuesta L; Section of Genetics, International Agency for Research on Cancer (IARC-WHO), Lyon, France. Electronic address: fernandezcuestal@iarc.fr.
EBioMedicine ; 48: 191-202, 2019 Oct.
Article em En | MEDLINE | ID: mdl-31648983
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pleurais / Suscetibilidade a Doenças / Microambiente Tumoral / Neoplasias Pulmonares / Mesotelioma / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: EBioMedicine Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pleurais / Suscetibilidade a Doenças / Microambiente Tumoral / Neoplasias Pulmonares / Mesotelioma / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: EBioMedicine Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França